2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Disease Models, Animal in 1 studies
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
Excerpt | Relevance | Reference |
---|---|---|
"Our findings showed that posaconazole could be useful in the treatment of zygomycosis." | 3.76 | In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility. ( Barchiesi, F; Giannini, D; Orlando, F; Spreghini, E, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Spreghini, E | 1 |
Orlando, F | 1 |
Giannini, D | 1 |
Barchiesi, F | 1 |
1 other study available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Disease Models, Animal
Article | Year |
---|---|
In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
Topics: Amphotericin B; Animals; Antifungal Agents; Child; Disease Models, Animal; Humans; Male; Mice; Micro | 2010 |